The plasminogen activator inhibitor “paradox” in cancer
Authors:
- Bernd R. BinderBBBernd R. Binder
- Judit MihalyJMJudit Mihaly
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 118 (2) , 116-124
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cellsBiochemical Journal, 2007
- Tumoral and Choroidal VascularizationThe American Journal of Pathology, 2007
- The plasminogen activator and matrix metalloproteinase systems in colorectal cancerEuropean Journal of Cancer, 2003
- Proteases in brain tumour progressionActa Neurochirurgica, 2003
- Regulation of Rac1 activation by the low density lipoprotein receptor–related proteinJournal of Cell Biology, 2002
- Both u‐PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasisInternational Journal of Cancer, 2002
- Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer CellsJournal of Biological Chemistry, 2002
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Involvement of the [uPAR:uPA:PAI-1:LRP] Complex in Human Myogenic Cell MotilityExperimental Cell Research, 2000
- Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitorsGene Therapy, 1999